MLN8054

Overview

MLN8054 is a potent, selective and orally available aurora A kinase inhibitor with an IC 50 of 4 nM.

Application

Products | Products > Disease Areas > Pancreatic Cancer | Products > Disease Areas > Digestive System Cancer | Products > Disease Areas > Cancer | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Leukemia/Lymphoma/Myeloma | Products > Disease Areas > Blood Disease | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Epigenetics | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Aurora Kinase

Product Information

• Catalog No.: HY-10180
• CAS No.: 869363-13-3
• Molecular Formula: C25H15ClF2N4O2
• Molecular Weight: 476.86
• Purity: 99.01%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 1 year , -20°C, 6 months
• Solubility: 2.5 mg/mL (5.24 mM); Suspended solution; Need ultrasonic
• Availability: In-stock

Source

Original product source